Document is current
Any future updates will be listed below
-
Authors
Izumi, Keishiro
Iyoda, Tomokazu
Yokota, Atsuko
Kanno, Masahito
Hoshi, Masahiro
Tokuda, Emi
Sasaki, Eisaku
Kanazawa, Kenya
Kuroda, Junko
Saji, Shigehira
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 7 October 2024
First Online: 18 October 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects (Ministry of Health, Labour and Welfare of Japan). The study was approved by the Ethics Committee of Fukushima Medical University (approval number: 29166). Informed consent was obtained from all individuals included in the study.
: Shigehira Saji has received speaker and consultant honoraria from Company Chugai, Kyowa Kirin, MSD, Novartis, Eisai, Takeda, Daiichi Sankyo, Eli Lilly, Astra Zeneca, Pfizer, Taiho, Ono, Nipponkayaku, Gilead and Exact Science. Emi Tokuda has received speaker honoraria from Company Chugai, Kyowa Kirin, MSD, Daiichi Sankyo, Astra Zeneca, Pfizer, Taiho, and Johnson and Johnson. The other authors declare that they have no competing interests.
